Tech Company Financing Transactions

Arsanis Funding Round

NeoMed Management, OrbiMed and Polaris Partners joined a $20 million Series B venture round for Arsanis. This venture round was announced on 9/3/2013.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B

NeoMed Management (Lead Investor) (Claudio Nessi)

OrbiMed (Carl Gordon)

Polaris Partners (Terry McGuire)

SV Health Investors (Michael Ross)

Proceeds Purpose
We will use these funds to focus on the clinical development of our lead program against Staphylococcus aureus, ASN-100, while maturing our pipeline of anti-infective antibodies against other relevant pathogens.

Company Information

Company Status
Mailing Address
890 Winter St. 230
Waltham, MA 02451
Email Address
Not Recorded
Arsanis (NASDAQ: ASNS) is a biosciences company developing infectious disease treatments based on bacterial protein and carbohydrate antigens.
Arsanis LinkedIn Company Profile
Social Media
Arsanis Company Twitter Account
Company News
Arsanis News
Arsanis on Facebook
Arsanis on YouTube

Management Team

Email & Social
Chief Executive Officer
René Russo
  René Russo LinkedIn Profile  René Russo Twitter Account  René Russo News  René Russo on Facebook
Chief Medical Officer
Chris Stevens
  Chris Stevens LinkedIn Profile  Chris Stevens Twitter Account  Chris Stevens News  Chris Stevens on Facebook
Chief Operating Officer
Michael Gray
  Michael Gray LinkedIn Profile  Michael Gray Twitter Account  Michael Gray News  Michael Gray on Facebook
Chief Scientific Officer
Eszter Magy
  Eszter Magy LinkedIn Profile  Eszter Magy Twitter Account  Eszter Magy News  Eszter Magy on Facebook
VP - Bus. Development
David Mantus
  David Mantus LinkedIn Profile  David Mantus Twitter Account  David Mantus News  David Mantus on Facebook



Browse more venture capital transactions:

Prev: 9/2/2013: OpenCare venture capital transaction
Next: 9/3/2013: QuantiaMD venture capital transaction


Share this article


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary